Clinical features and treatment of overdosage of monoamine oxidase inhibitors and their interaction with other psychotropic drugs. 1972

E Ciocatto, and G Fagiano, and G L Bava

UI MeSH Term Description Entries
D007099 Imipramine The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. Imidobenzyle,Imizin,4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2),Imipramine Hydrochloride,Imipramine Monohydrochloride,Imipramine Pamoate,Janimine,Melipramine,Norchlorimipramine,Pryleugan,Tofranil
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D009526 Nialamide An MAO inhibitor that is used as an antidepressive agent.
D011041 Poisoning A condition or physical state produced by the ingestion, injection, inhalation of or exposure to a deleterious agent. Poisonings
D004336 Drug Antagonism Phenomena and pharmaceutics of compounds that inhibit the function of agonists (DRUG AGONISM) and inverse agonists (DRUG INVERSE AGONISM) for a specific receptor. On their own, antagonists produce no effect by themselves to a receptor, and are said to have neither intrinsic activity nor efficacy. Antagonism, Drug,Antagonisms, Drug,Drug Antagonisms
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females

Related Publications

E Ciocatto, and G Fagiano, and G L Bava
November 1965, Proceedings of the Royal Society of Medicine,
E Ciocatto, and G Fagiano, and G L Bava
August 2001, The Journal of pharmacy and pharmacology,
E Ciocatto, and G Fagiano, and G L Bava
January 1961, Recent advances in biological psychiatry,
E Ciocatto, and G Fagiano, and G L Bava
January 1962, Rassegna di studi psichiatrici,
E Ciocatto, and G Fagiano, and G L Bava
October 1983, Hospital & community psychiatry,
E Ciocatto, and G Fagiano, and G L Bava
April 1968, Diseases of the nervous system,
E Ciocatto, and G Fagiano, and G L Bava
December 1976, General pharmacology,
E Ciocatto, and G Fagiano, and G L Bava
April 1968, British medical journal,
E Ciocatto, and G Fagiano, and G L Bava
February 1991, Journal of clinical psychopharmacology,
E Ciocatto, and G Fagiano, and G L Bava
January 1969, Naunyn-Schmiedebergs Archiv fur Pharmakologie,
Copied contents to your clipboard!